News

Awakn Life Sciences Announces Listing on the Canadian Securities Exchange

Toronto, Ontario--(Newsfile Corp. - February 12, 2024) - Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a…

2 years ago

Tinley’s Announces Grant of Stock Options

Toronto, Ontario and Los Angeles, California--(Newsfile Corp. - February 12, 2024) - The Tinley Beverage Company Inc. (CSE: TNY) (OTCQB:…

2 years ago

CBD of Denver Inc. Reports January Revenue, Progress on Legislation in Germany and Business Highlights

Denver, Colorado--(Newsfile Corp. - February 12, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD), today announced revenue for January…

2 years ago

AlzeCure Pharma Broadcasts Live Expert Event on Alzheimer’s Around Highly Current Gamma-Secretase Modulators

STOCKHOLM, SE / ACCESSWIRE / February 12, 2024 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR),…

2 years ago

Poolbeg Pharma PLC Announces Market Opportunity for POLB 001 for CRS

Independent Research Confirms >$10bn Market Opportunity for POLB 001 as a Preventative Therapy for Cancer Immunotherapy-Induced Cytokine Release Syndrome (CRS)Former…

2 years ago

Ibogaine By David Dardashti Makes Statement on Public Concerns Regarding Fentanyl Distribution

David Dardashti Helping Our Clients is Our Top Priority. Miami, Feb. 10, 2024 (GLOBE NEWSWIRE) -- In light of the…

2 years ago

MAPS Congratulates Lykos Therapeutics on Acceptance of New Drug Application for MDMA-Assisted Therapy for PTSD

The FDA has accepted a New Drug Application filed by Lykos Therapeutics for MDMA-assisted therapy for PTSD The application was…

2 years ago

Vision Sensing Acquisition Corp. Announces Filing of Form 10-Q with the SEC For the Quarterly Period Ended September 30, 2023, Regaining Compliance with the Filing Requirement in Nasdaq Listing Rule 5250(c)(1)

MIAMI, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”) a special purpose…

2 years ago

New Late Breaking Preliminary Data Demonstrate Balt’s Squid™ Liquid Embolic May Improve Outcomes in Patients with Chronic Subdural Hematomas

BOSTON, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Balt, Inc., a global technology leader in neurovascular devices, today announced the presentation…

2 years ago

PickleJar Debuts “Win Now” Technology to Simplify Contesting Programs With Strategic Partners and Reward Fans

HOUSTON, TX, Feb. 09, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – PickleJar Entertainment Group, f/k/a NewRegen, Inc. (OTC:NREG) , a…

2 years ago